Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Interest & Investment Income (2020 - 2025)

Rani Therapeutics Holdings (RANI) has 6 years of Interest & Investment Income data on record, last reported at $68000.0 in Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 83.61% year-over-year to $68000.0; the TTM value through Sep 2025 reached $803000.0, down 61.36%, while the annual FY2024 figure was $1.8 million, 46.59% down from the prior year.
  • Interest & Investment Income reached $68000.0 in Q3 2025 per RANI's latest filing, down from $157000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $896000.0 in Q2 2023 and bottomed at $13000.0 in Q2 2021.
  • Average Interest & Investment Income over 5 years is $360210.5, with a median of $360000.0 recorded in 2024.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 5840.0% in 2023, then tumbled 83.61% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $16000.0 in 2021, then surged by 5012.5% to $818000.0 in 2022, then decreased by 17.48% to $675000.0 in 2023, then plummeted by 46.67% to $360000.0 in 2024, then plummeted by 81.11% to $68000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were $68000.0 in Q3 2025, $157000.0 in Q2 2025, and $218000.0 in Q1 2025.